Katharina Erlenbach‐Wünsch

ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin

Abbas Agaimy, Katharina Erlenbach‐Wünsch, Björn Konukiewitz et al. · Modern Pathology · 2013 · 125 citations · Full text

Neuroendocrine Neoplasms, Pancreatic Cancer, Pathology +8

PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis

Markus Hecht, Maike Büttner‐Herold, Katharina Erlenbach‐Wünsch et al. · European Journal of Cancer · 2016 · 125 citations

Medicine, Cancer Growth, Pathology +8

Loss of enhancer of zeste homologue 2 (EZH2) at tumor invasion front is correlated with higher aggressiveness in colorectal cancer cells

J. Böhm, Julienne K. Muenzner, Aylin Caliskan et al. · Journal of Cancer Research and Clinical Oncology · 2019 · 38 citations · Full text

Spatial distribution of FoxP3+ and CD8+ tumour infiltrating T cells reflects their functional activity

Rebecca Posselt, Katharina Erlenbach‐Wünsch, Matthias Haas et al. · Oncotarget · 2016 · 37 citations · Full text

Comprehensive screening for mutations associated with colorectal cancer in unselected cases reveals penetrant and nonpenetrant mutations

Cornelia Kraus, Tilman T. Rau, Philipp Lux et al. · International Journal of Cancer · 2014 · 25 citations

Consecutive Crc Patients, Somatic Variant, Nonpenetrant Mutations +13